Safety & Toxicity

·

News

Colorado Campaign Warns Young Adults About Psychedelic Risks

Colorado Campaign Warns Young Adults About Psychedelic Risks

Psilocybin mushrooms

What they found

The Before You Trip campaign notes 8.9% of psychedelic users report lingering impairment.

The Before You Trip campaign notes 8.9% of psychedelic users report lingering impairment.

The number

8.9% of users report lingering impairment

How solid is it?

n/a

n/a

Not a study

Not a study

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin

psilocybin

Published in

The Denver Post

The Denver Post

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

Pause Before the Dose

Pause Before the Dose

A new Colorado campaign, Before You Trip, is educating young adults on the risks of psychedelics like psilocybin, filling a major gap in harm reduction. Backed by scientists and families affected by psychedelic-related trauma, the campaign shares sobering stats: 8.9% of users report lingering impairment, and fatalities, though rare, are often misunderstood. With influencers, safety checklists, and science-backed info, it urges Gen Z to reflect before experimenting.

A new Colorado campaign, Before You Trip, is educating young adults on the risks of psychedelics like psilocybin, filling a major gap in harm reduction. Backed by scientists and families affected by psychedelic-related trauma, the campaign shares sobering stats: 8.9% of users report lingering impairment, and fatalities, though rare, are often misunderstood. With influencers, safety checklists, and science-backed info, it urges Gen Z to reflect before experimenting.

Microdosing Breakthrough, Reishi vs. Aging, and Fungi Protein

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.